Thought Leaders:

John Nosta, Founder, NostaLab (Moderator)
Sharon Callahan, CEO, TBWAWorldHealth; Chief Client Officer, Omnicom Health Group
Patrick Lindsay, President, United BioSource Corporation
Wendy White, Chief Patient Officer, Vitrisa Therapeutics
Ben Wiegand, Ph.D., Global Head, World Without Disease Accelerator, Janssen Pharmaceutical Companies of Johnson & Johnson

November 7, 2018

Enjoy the Executive Forum.

Thought Leader:

A variety of industry visionaries

November 7, 2018

Enjoy this visual recap of the 2018 PharmaVOICE 100 Celebration. Dozens of photos, video clips, and interviews showcase the amazing talent in our industry. This year’s core topic was Transformation.

Thought Leader:

Dan Limbach - Producer, PharmaVOICE Webcast Network

August 23, 2018

This video explains what the PharmaVOICE Healthy Opinions webcast program is all about.

Thought Leader:

Dan Limbach, Producer - PharmaVOICE Webcast Network

August 23, 2018

This white board “Explainer” video describes how you can re-purpose one piece of content for numerous other uses. PharmaVOICE has the expertise and knowledge to help you.

Thought Leaders:

Donald A. Deieso, Chairman and CEO, WIRB-Copernicus Group
Jill Johnston, President, Site Activation, WIRB-Copernicus Group

July 31, 2018

Dr. Deieso and Ms. Johnston discuss how Precision Medicine is impacting clinical trials, the opportunities provided by Precision Medicine, their partnership with Informed DNA, and the evolution of the Center for Genetics and Precision Medicine in Clinical Trials.

Thought Leader:

Andy Alasso, Global Vice President, Product Management, Oracle Health Sciences

July 30, 2018

Mr. Alasso discusses the biggest challenges for sponsors and CROs in exploiting new technology in clinical research, enhancing the patient experience, the impact of technology on clinical trials in the next 3-5 years, and the biggest trend seen at DIA.

Thought Leader:

Todd Phillips, Director, Global Regulatory Affairs, Cardinal Health

July 30, 2018

Todd Phillips talks about the importance or Patient-reported Outcomes (PROs), therapeutic areas using PROs, FDA guidances on PROs, and how pharma can incorporate PROs into their development programs.

Thought Leader:

Cynthia Verst, President, R&D Design and Delivery Innovation, IQVIA

July 26, 2018

Ms. Verst discusses how IQVIA addresses pain points in clinical research, using Real-world Data, advanced analytics, and machine learning, how technology enables collaboration, and how rare disease is driving productivity in clinical trials.

Thought Leader:

Annette Stemhagen, DrPH, FISPE, Senior Vice President & Chief Science Officer of Safety, Epidemiology, Registries & Risk Management, UBC

July 26, 2018

Dr. Stemhagen discusses using a Real-world Evidence strategy in clinical development, the practical applications of RWE, the long-term results of RWE, and trends seen while at DIA.

Thought Leader:

Todd McGrath, VP of U.S. Operations, Medical Research Network

July 26, 2018

Mr. McGrath discusses MRN’s growth in the industry due to a patient-centric approach to recruitment and retention, the emergence of virtual trials, the inherent challenges of patient recruitment, and their partnership with Patient Primary to provide a patient travel support … Read More »

Thought Leader:

Beenu Kapoor, Senior Director, Consulting, Life Sciences, Cognizant

July 26, 2018

Ms. Kapoor talks about Cognizant’s Shared Investigator Platform, how it ties in with TransCelerate members, the qualitative and quantitative benefits of sponsors and sites using the platform, and interesting trends seen while at DIA.

Thought Leader:

Azhar Kalim, Chief Commercial Officer, ACM Global Laboratories

July 25, 2018

Mr. Kalim discusses their two major acquisitions, their Smarter Testing for Oncology services, the ACM rebranding, and what they looked for at DIA this year.

Thought Leader:

Jackie Kent, SVP, Head of Product, Medidata

July 25, 2018

Ms. Kent discusses the role of technology in the life-sciences, employing patient-centric clinical trials, and mentoring women in the industry.

Thought Leader:

Lisa Dilworth, VP, Rare and Orphan Diseases, Synteract

July 25, 2018

Ms. Dilworth discusses the key challenges in operationalizing rare disease trials, the most exciting trends in rare disease trials, and what drives her to work in the rare disease space.

Thought Leader:

Karim Damji, Senior VP, Product Management and Marketing, Saama Technologies

July 25, 2018

Mr. Damji discusses exciting trends in clinical trials, how AI and Natural Language Understanding will impact drug development, and optimizing the clinical journey using validated cloud-based solutions.

Thought Leader:

Bruce Morimoto, PhD, VP, Scientific Affairs

July 25, 2018

Dr. Morimoto discusses scientific breakthroughs and their impact on drug development efforts, expertise in vaccine research, and using biomarkers in clinical research.

Thought Leader:

Qi Li, M.D., Physician Executive, InterSystems

July 24, 2018

Dr. Li talks about supporting the Life Sciences industry, the clinical trials ecosystem, and leveraging Real World Data in clinical research.

Thought Leader:

Peter Benton, President and Chief Operating Officer, Worldwide Clinical Trials

July 23, 2018

Mr. Benton discusses the evolution of the CRO industry, the sustainability of the current M&A model, what sponsors should look for in a CRO partner, how they maintain their company culture, and their vision for the future.

Thought Leader:

Brett Kleger, Chief Commercial Officer, DrugDev, an IQVIA company

July 23, 2018

Mr. Kleger discusses alleviating the technology burden on clinical trial sites, the future of clinical trials, and technology trends and strategies for clinical research.

Thought Leader:

Jason Monteleone, Chief Executive Officer

July 23, 2018

Mr. Monteleone discusses challenges CROs face working with sponsors, the importance of focusing on regulatory and strategic development issues, opportunities for small/mid-sized CROs, critical aspects of a good partnership, and understanding the dynamic changes in technology … Read More »

Thought Leader:

Kevin Duffy, Global VP, Life Sciences, KellyOCG

July 23, 2018

Mr. Duffy discusses trending skills in the life sciences industry, the gig economy, and attracting the best and brightest employees.

Thought Leader:

Jason Casarella, Executive Vice President, Advanced Clinical

July 23, 2018

Mr. Casarella discusses why large clinical development service providers are slow to adapt to changes in technology, the impact of ICH E6(R2), optimal strategies for talent acquisition, and studies for oncology and rare diseases.

Thought Leaders:

Eric Hayashi, President & CEO
Jeff Mayhew, Chief Development Officer

July 23, 2018

Mr. Hayashi discusses LabConnect’s collaboration with Symphony Clinical Research, hot topics at DIA, and technology as an industry connector. Mr. Hayhew discusses trends and issues related to PBMC isolation within clinical trials.

Thought Leader:

Kunsan Kim, SVP Strategy, precisioneffect

March 7, 2018

This is a PharmaVOICE-exclusive PodcastPlus version of the original audio podcast. It is enhanced with visuals to provide additional content. Advertising agencies have always been known by their ability to create amazingly creative campaigns. Its how they’ve built reputation … Read More »

Thought Leader:

Bhaskar Sambasivan, Senior V.P. & Global Markets Leader, Cognizant Life Sciences

August 1, 2017

Bhaskar Sambasivan discusses how executives can leverage digital technologies, key areas of focus for Life Sciences companies, managing numerous aspects in the move towards patient-centricity, and how platforms can unlock new revenue streams and provide cost savings.

Thought Leader:

Jim Corrigan, President & CEO, ERT

August 1, 2017

Jim Corrigan discusses the risks associated with clinical trials, clearing the hurdle of paper in clinical research, the most promising and exciting advancements in the eclinical space, where the eclinical space will be five years from now, and the new era of collaboration.

Thought Leader:

Richard Scheyer, M.D. Vice President, Medical Affairs, Medpace

July 28, 2017

Richard Scheyer discusses the importance of patient-centricity in rare disease studies, the benefits of customized studies, connecting with key investigators, and the increased interest in rare diseases.

Thought Leader:

Matthew J. Neal, Senior Director, Product Management, Regulatory Solutions, PAREXEL

July 28, 2017

Matthew J. Neal discusses the biggest challenge that regulatory and clinical systems need to address, how technology can be used in this cause, how global health authorities are dealing with these issues, and how data is at the center of the movement towards patient-centrici … Read More »

Thought Leader:

Robert A. Carlson, MD, Vice President, Medical Affairs, ACM Global Laboratories

July 28, 2017

Robert A. Carlson, MD discusses digital pathology as it relates to clinical trials, how patients benefit, as well as the cause and effect of the diminishing number of pathologists.

Thought Leader:

Jeff Wendel, MBA, President & CEO, Chesapeake IRB

July 28, 2017

Jeff Wendel discusses how an IRB can streamline study startups, trends in regulatory and site identification, and working with academic medical centers to insure compliance with sIRB policy.

Thought Leader:

Staci McDonald PharmD, Executive Director, Scientific Clinical Operations, Celerion

July 26, 2017

Staci McDonald, PharmD discusses how Celerion’s business is changing with the emergence of biosimilar drugs, why biosimilar developers choose to work with Celerion, and what they have learned in the course of their biosimilar research.

Thought Leader:

Simon J. Griffin, CEO, Lifelines Neurodiagnostic Systems, Inc.

July 21, 2017

Simon J. Griffin discusses the merits of adding a Cloud-based video EEG component to a trial protocol, which therapeutic categories benefit the most from this, and how a Cloud strategy can improve recruitment and randomization goals.

Thought Leader:

David Connelly, CEO, Cmed

July 21, 2017

David Connelly discusses Cmed’s new Encapsia product, its benefits in the clinical trials process, how sponsors can use it, and its current availability.

Thought Leader:

Andrew Cassel, Managing Director, Data and Analytics, Medidata Solutions

July 21, 2017

Andrew Cassel discusses Machine Learning technology, and the practical applications of predictive modeling and genomics in clinical trials.

Thought Leader:

Judith Ng-Cashin, M.D. Chief Scientific Officer, INC Research

July 21, 2017

Judith Ng-Cashin discusses running clinical trials for rare diseases, including critical factors, engaging patients, additional stakeholders, and the growing amount of clinical research in the rare disease space.

Thought Leader:

Bill Byrom, Senior Director of Product Innovation, ICON

July 21, 2017

Bill Byrom discusses Bring-your-own-device (BYOD) adoption by patients in clinical trials, industry concerns, supporting evidence in favor of BYOD adoption, and thoughts on the next frontier in clinical trials.

Thought Leader:

Eric Delente, President, New Patient Solutions, DrugDev

July 21, 2017

Eric Delente discusses how eConsent differs from the traditional informed consent procedures, the barriers keeping some organizations from converting to digital, lessons learned regarding eConsent, and how eConsent can make monitoring easier.

Thought Leader:

Donald Deieso, Ph.D., Chairman & CEO, WIRB Copernicus Group

July 21, 2017

Donald A. Deieso PhD discusses the changing landscape for clinical and IRB services, transformative improvements in clinical research, the recent acquisitions by WIRB-Copernicus Group, and how their alliance with Huron is improving the efficiency of clinical trials.

Thought Leaders:

Alastair MacDonald, Executive Director, Real World and Late Phase
Janet Baldwin, Vice President, Real World and Late Phase"

July 21, 2017

Alastair MacDonald and Janet Baldwin discuss why Real World Evidence (RWE) is important today, insights on late-stage research, when companies should start thinking about RWE generation, recommendations on identifying and collecting RWE, and the future of RWE.

Thought Leader:

Scott Gray, CEO, Clincierge

July 19, 2017

Scott Gray discusses why recruiting a diverse patient base in clinical trials is important, the barriers to achieving patient diversity, tips for ensuring greater diversity among patients, the ROI for such practices, and an example of one of his success stories.

Thought Leader:

Jignesh Patel, Principal Scientist, Clinical Research, Cardinal Health Regulatory Sciences

July 19, 2017

Jignesh Patel discusses adaptive clinical trials, how this process relates to the FDA and the 21st Century Cures Act, its benefits and limitations, and when it should be used in clinical research.

Thought Leader:

Kevin Duffy, Global Vice President, Global Solutions, Life Sciences & Healthcare, Kelly OCG

July 19, 2017

Kevin Duffy discusses talent in the Life Sciences and Healthcare space, how to keep millennials on staff, and the impact of technology on talent.

Thought Leader:

Jason Casarella, Executive Vice President, Business Development and Marketing, Advanced Clinical

July 19, 2017

Jason Casarella discusses trends in the CRO market, challenges sponsors face today, how the industry is reponding to these challenges, and the rate of collaboration between companies in the industry.

Thought Leader:

Nicholas Kenny, PhD, Executive Vice President, Oncology & Hematology, INC Research

July 19, 2017

Nicholas Kenny discusses innovative trial designs, collaboration in clinical research, the impact of collaboration to INC Research, sites, and sponsors, and the evolution of immunotherapy and combination trials.

Thought Leader:

Peter Benton, President & COO, Worldwide Clinical Trials

July 19, 2017

Peter Benton discusses current trends in the CRO space, how Worldwide Clinical Trials is responding to these trends, challenges sponsors currently face, what the “Cure for the Common CRO” means, how to attract the best new talent through cultural changes, and how to address … Read More »

Thought Leader:

Andrew Schachter, CEO and Founder, Axiom Real-Time Metrics

July 19, 2017

Andrew Schachter discusses how small/mid-sized life sciences organizaions select EDC vendors, the concept of “Unified” in an eClinical suite, the pain points for end-users, and Axiom’s Fusion eClinical Suite.

Thought Leader:

Abhishek Shankar, Vice President & Head, Life Sciences, North America, HCL Technologies

July 29, 2015

Abhishek Shankar discusses the value of patient-centricity and and how the cloud is transforming operations in the life-sciences industry.

FEEDBACK